| Sales | 60.5a | 58.72a |
| Other revenue | 1.9a | 1.73a |
| Revenue | 62.4a | 60.44a |
| Cost of sales | -16.28a | -16.36a |
| Research and development | -15.3a | -14.2a |
| Selling, general and administration | -14.9a | -14.88a |
| Other operating income (expense) | -2.5a | 0.39a |
| Operating profit | 13.42a | 15.4a |
| Financing costs | -1.41a | -1a |
| Other financial income (expense) | -0.21a | -0.32a |
| Profit before taxes | 11.79a | 14.08a |
| Income taxes | -2.61a | -1.72a |
| Net income | 9.19a | 12.36a |
| Attributable to | — | — |
| Roche shareholders | 8.28a | 11.5a |
| Non-controlling interests | 0.91a | 0.86a |